Posts by Sandra Ansanay-Alex
CHF 40,000 For Diatheris
The Geneva-based biotech startup won Venture Kick’s second stage of financial and entrepreneurial support. The project aims to achieve optimal glycemic control while minimizing the risks of hypoglycemia and ketoacidosis Type 1 diabetes (T1D) patients face significant challenges in achieving proper glycemic control without the risk of life-threatening hypoglycemia and ketoacidosis. Despite insulin therapy…
Read MoreFirst in Human Recording of Brain Activities Achieved by Neurosoft Bioelectronics
The Swiss start-up created a stretchable high-channel electrode grid that was successfully used in a first-in-human clinical study in a hospital in Houston Texas (USA), involving 3 patients. They were tested intra-operatively in the context of epilepsy and brain tumor surgery. Neurosoft Bioelectronics is getting closer to treating severe brain disorders. Under the…
Read MoreCHUV@home: an application to monitor patients after surgery
Nearly 1,800 people have already used the CHUV@home application since it was launched in 2021. Patients who have undergone surgery can benefit from 24-hour remote monitoring by the nursing team at the CHUV’s Centre de télésuivi. Getting patients home safely is a priority for the CHUV. The CHUV@home application provides support and assistance…
Read MorePôle Santé Campus in Sion – Foundation stone laid
The Pôle Santé Campus in Valais will bring together on the same site training activities in health and social work, as well as research and innovation in the fields of health and sport. The project is valued at CHF 96.6 million. The campus will bring together the expertise of the Haute Ecole de Santé…
Read MoreGenolier Innovation Hub: an ambitious medical center
In the heart of the Swiss Health Valley, the holding company AEVIS VICTORIA SA is investing more than CHF 100 million in a new medical hub. The ambition is to bring together health care players in a real clinic situation with a luxury hotel experience. The construction of this 25,000 m2 building dedicated…
Read MoreA tool for predicting the future of Alzheimer’s patients
A team from the University and the HUG has determined which imaging technique is best for early detection of the degenerative disease. A recent imaging technique, PET tau, is capable of predicting cognitive decline in Alzheimer’s patients, and therefore of treating them better – early diagnosis, before the brain is too badly damaged,…
Read MoreVenture Leaders Medtech 2023
10 medtech projects were selected to join the Swiss National Startup team that will travel to Boston and Cambridge next September to meet investors in industry leaders. For the third consecutive year, the dedicated program will represent Swiss Medtech innovation in the United States. “From novel surgery solutions to AI-driven solution to improve patients…
Read MoreBearmind reaches CHF 2 million funding
The start-up develops sensors and algorithms to provide a real-time assessment of the risk of concussion for professional athletes. The round was led by H.Hentsch Asset Management, and included participation from AVANTECA Partners AG, NP Consulting, Swisspreneur, several business angels. LangLeven Group a Montreal-based Sports tech VC with a remarkable track record in the…
Read MoreAn app to empower women during their menopause
PhenomX Health SA, a femtech start–up based in Biopôle, launches a wellness and precision nutrition app for menopause care in Switzerland, with the aim to empower women during their menopause transition and healthy ageing. PhenomX Health SA is a Swiss, EPFL FemTech accelerator (Tech4Eva) Alumni, creating an advanced technology ecosystem for menopause (from early &…
Read MoreUNIGE scientists identified genes involved in the progression of cancer
Tissues, blood vessels, cells: tumours develop in a complex ecosystem known as the tumour microenvironment. A team from the University of Geneva (UNIGE) has succeeded in deciphering a rule governing this environment by identifying a pair of genes whose expression can accelerate, or slow down, the progression of cancer. These promising results are published in…
Read More